Employing the promiscuity of lantibiotic biosynthetic machineries to produce novel antimicrobials. (Q38945513)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27591436%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

review article

1 reference

title

Employing the promiscuity of lantibiotic biosynthetic machineries to produce novel antimicrobials (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27591436%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

author

Manuel Montalbán-López

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27591436%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

author name string

Auke J van Heel

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27591436%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Oscar P Kuipers

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27591436%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

publication date

2 September 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27591436%20AND%20SRC:MED&resulttype=core&format=json

FEMS Microbiology Reviews

22 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27591436%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27591436%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27591436%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

page(s)

5-18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27591436%20AND%20SRC:MED&resulttype=core&format=json

A new hybrid bacteriocin, Ent35-MccV, displays antimicrobial activity against pathogenic Gram-positive and Gram-negative bacteria

22 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

The vancomycin-nisin(1-12) hybrid restores activity against vancomycin resistant Enterococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Lantibiotics: diverse activities and unique modes of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Identification of a novel two-peptide lantibiotic, lichenicidin, following rational genome mining for LanM proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

'Old' antibiotics for emerging multidrug-resistant bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Photochemical cleavage of leader peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Facile Removal of Leader Peptides from Lanthipeptides by Incorporation of a Hydroxy Acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

A general method for fluorescent labeling of the N-termini of lanthipeptides and its application to visualize their cellular localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Crystal structure of the peptidyl-cysteine decarboxylase EpiD complexed with a pentapeptide substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

antiSMASH 2.0--a versatile platform for genome mining of secondary metabolite producers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Organization of the genes encoding the biosynthesis of actagardine and engineering of a variant generation system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Antibacterial activity of the novel semisynthetic lantibiotic NVB333 in vitro and in experimental infection models

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Postgenomic strategies in antibacterial drug discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Expanded genetic code for the engineering of ribosomally synthetized and post-translationally modified peptide natural products (RiPPs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

A prevalent peptide-binding domain guides ribosomal natural product biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Tackling antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Heterologous expression, biosynthesis, and mutagenesis of type II lantibiotics from Bacillus licheniformis in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Much of the microcin J25 leader peptide is dispensable

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Posttranslational conversion of L-serines to D-alanines is vital for optimal production and activity of the lantibiotic lacticin 3147

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Bacteriocins - a viable alternative to antibiotics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

The future of peptide-based drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Evaluation of NVB302 versus vancomycin activity in an in vitro human gut model of Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Brominated Variant of the Lantibiotic NAI-107 with Enhanced Antibacterial Potency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Production of the Bsa lantibiotic by community-acquired Staphylococcus aureus strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Lantibiotics: promising candidates for future applications in health care

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

The enterococcal cytolysin synthetase has an unanticipated lipid kinase fold

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

21 January 2018

Lantibiotic resistance

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Insights into the mechanism of peptide cyclodehydrations achieved through the chemoenzymatic generation of amide derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Encapsulating bacteria in agarose microparticles using microfluidics for high-throughput cell analysis and isolation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

The lantibiotic peptide labyrinthopeptin A1 demonstrates broad anti-HIV and anti-HSV activity with potential for microbicidal applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

The bacteriocin nisin, an effective agent for the treatment of staphylococcal mastitis during lactation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Peptide therapeutics: current status and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Microbisporicin gene cluster reveals unusual features of lantibiotic biosynthesis in actinomycetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

In vitro reconstitution and substrate specificity of a lantibiotic protease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Characterization of the stereochemical configuration of lanthionines formed by the lanthipeptide synthetase GeoM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

In vitro activity of the nisin dehydratase NisB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Lantibiotics from Geobacillus thermodenitrificans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Serine protease EpiP from Staphylococcus epidermidis catalyzes the processing of the epidermin precursor peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Human serum binding and its effect on the pharmacodynamics of the lantibiotic MU1140.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Development and validation of a LC-MS quantification method for the lantibiotic MU1140 in rat plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Challenges for the oral delivery of macromolecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Discovery of unique lanthionine synthetases reveals new mechanistic and evolutionary insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Evaluation of a nisin-eluting nanofiber scaffold to treat Staphylococcus aureus-induced skin infections in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Modification of an effector strain for replacement therapy of dental caries to enable clinical safety trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

In vivo incorporation of multiple noncanonical amino acids into proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Biosynthesis of paenibacillin, a lantibiotic with N-terminal acetylation, by Paenibacillus polymyxa

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Discovery and Characterization of Bicereucin, an Unusual d-Amino Acid-Containing Mixed Two-Component Lantibiotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Use of collateral sensitivity networks to design drug cycling protocols that avoid resistance development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

A glycosylated, labionin-containing lanthipeptide with marked antinociceptive activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Antimicrobial mechanism of lantibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Dissecting reactions of nonlinear precursor peptide processing of the class III lanthipeptide curvopeptin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Structural basis of lantibiotic recognition by the nisin resistance protein from Streptococcus agalactiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Manipulation of innate immunity by a bacterial secreted peptide: lantibiotic nisin Z is selectively immunomodulatory

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Non-proteinogenic amino acids in lacticin 481 analogues result in more potent inhibition of peptidoglycan transglycosylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Discovery, biosynthesis, and engineering of lantipeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Chemical synthesis of the lantibiotic lacticin 481 reveals the importance of lanthionine stereochemistry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Transcriptome analysis reveals mechanisms by which Lactococcus lactis acquires nisin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Deuterium labeled peptides give insights into the directionality of class III lantibiotic synthetase LabKC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Purification and characterization of EpiD, a flavoprotein involved in the biosynthesis of the lantibiotic epidermin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Engineering the heterologous expression of lanthipeptides in Escherichia coli by multigene assembly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

In vivo pharmacokinetics and pharmacodynamics of the lantibiotic NAI-107 in a neutropenic murine thigh infection model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

In vitro mutasynthesis of lantibiotic analogues containing nonproteinogenic amino acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Platforms for antibiotic discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Structure and mechanism of the lantibiotic cyclase involved in nisin biosynthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Dissection of the bridging pattern of bovicin HJ50, a lantibiotic containing a characteristic disulfide bridge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

A new antibiotic kills pathogens without detectable resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Characteristics of the bovicin HJ50 gene cluster in Streptococcus bovis HJ50.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Biosynthesis, immunity, regulation, mode of action and engineering of the model lantibiotic nisin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Production of a class II two-component lantibiotic of Streptococcus pneumoniae using the class I nisin synthetic machinery and leader sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

The flavoprotein MrsD catalyzes the oxidative decarboxylation reaction involved in formation of the peptidoglycan biosynthesis inhibitor mersacidin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Characterization of a Multipeptide Lantibiotic Locus in Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Minimum Information about a Biosynthetic Gene cluster.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Pinensins: the first antifungal lantibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Microbial engineering of dehydro-amino acids and lanthionines in non-lantibiotic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Posttranslational Peptide-Modification Enzymes in Action: Key Roles for Leaders and Glutamate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Are bacteriocins underexploited? Novel applications for old antimicrobials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

MICs of mutacin B-Ny266, nisin A, vancomycin, and oxacillin against bacterial pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Lantibiotic Reductase LtnJ Substrate Selectivity Assessed with a Collection of Nisin Derivatives as Substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Lanthionine introduction into nukacin ISK-1 prepeptide by co-expression with modification enzyme NukM in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Nine post-translational modifications during the biosynthesis of cinnamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Congeneric lantibiotics from ribosomal in vivo peptide synthesis with noncanonical amino acids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

An engineered lantibiotic synthetase that does not require a leader peptide on its substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Follow the leader: the use of leader peptides to guide natural product biosynthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Lanthipeptides: chemical synthesis versus in vivo biosynthesis as tools for pharmaceutical production

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Structure and tRNA Specificity of MibB, a Lantibiotic Dehydratase from Actinobacteria Involved in NAI-107 Biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Structure and mechanism of the tRNA-dependent lantibiotic dehydratase NisB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Substrate Specificity of the Lanthipeptide Peptidase ElxP and the Oxidoreductase ElxO

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Targeting of gastrointestinal tract for amended delivery of protein/peptide therapeutics: strategies and industrial perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Requirements of the engineered leader peptide of nisin for inducing modification, export, and cleavage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Mechanistic aspects of lanthipeptide leaders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Rethinking the composition of a rational antibiotic arsenal for the 21st century

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Lantibiotic structures as guidelines for the design of peptides that can be modified by lantibiotic enzymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Dissection and modulation of the four distinct activities of nisin by mutagenesis of rings A and B and by C-terminal truncation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Recognition sequences and substrate evolution in cyanobactin biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Cloning and analysis of the planosporicin lantibiotic biosynthetic gene cluster of Planomonospora alba.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Production of lantipeptides in Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Challenges of antibacterial discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

The Clostridium difficile cpr locus is regulated by a noncontiguous two-component system in response to type A and B lantibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

New Insights into Nisin's Antibacterial Mechanism Revealed by Binding Studies with Synthetic Lipid II Analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

The challenge of the lantibiotics: synthetic approaches to thioether-bridged peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Recent advances in synthetic analogues of lantibiotics: What can we learn from these?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Substrate control in stereoselective lanthionine biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

The Enterococcal Cytolysin Synthetase Coevolves with Substrate for Stereoselective Lanthionine Synthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Structural characterization of four prochlorosins: a novel class of lantipeptides produced by planktonic marine cyanobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

The sequence of the enterococcal cytolysin imparts unusual lanthionine stereochemistry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

The MprF protein is required for lysinylation of phospholipids in listerial membranes and confers resistance to cationic antimicrobial peptides (CAMPs) on Listeria monocytogenes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

A price to pay for relaxed substrate specificity: a comparative kinetic analysis of the class II lanthipeptide synthetases ProcM and HalM2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

An in-vitro investigation of the antibacterial effect of nisin in root canals and canal wall radicular dentine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Circumventing the effect of product toxicity: development of a novel two-stage production process for the lantibiotic gallidermin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

BAGEL3: Automated identification of genes encoding bacteriocins and (non-)bactericidal posttranslationally modified peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Discovery, Production and Modification of Five Novel Lantibiotics Using the Promiscuous Nisin Modification Machinery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Evaluating the feasibility of lantibiotics as an alternative therapy against bacterial infections in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Designing and producing modified, new-to-nature peptides with antimicrobial activity by use of a combination of various lantibiotic modification enzymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Cloning and engineering of the cinnamycin biosynthetic gene cluster from Streptomyces cinnamoneus cinnamoneus DSM 40005

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Structure of the nisin leader peptidase NisP revealing a C-terminal autocleavage activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Michael-type cyclizations in lantibiotic biosynthesis are reversible.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Post-translational Introduction of D-Alanine into Ribosomally Synthesized Peptides by the Dehydroalanine Reductase NpnJ

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Lacticin 481 synthetase as a general serine/threonine kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Product Formation by the Promiscuous Lanthipeptide Synthetase ProcM is under Kinetic Control

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

High divergence of the precursor peptides in combinatorial lanthipeptide biosynthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Evolution of lanthipeptide synthetases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Incorporation of tryptophan analogues into the lantibiotic nisin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

The length of a lantibiotic hinge region has profound influence on antimicrobial activity and host specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Potentiating the Activity of Nisin against Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FFEMSRE%2FFUW034

21 January 2018

Identifiers

DOI

10.1093/FEMSRE/FUW034

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27591436%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

1 reference